The role of (pro)renin receptor and its soluble form in cardiovascular diseases
Frontiers in Cardiovascular Medicine · 02.02.2023 · 10
DOI: 10.3389/fcvm.2023.1086603 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 02.02.2023. Verfasst von Boyang Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The renin-angiotensin system (RAS) is a major classic therapeutic target for cardiovascular diseases. In addition to the circulating RAS, local tissue RAS has been identified in various tissues and plays roles in tissue inflammation and tissue fibrosis. (Pro)renin receptor (PRR) was identified as a new member of RAS in 2002. Studies have demonstrated the effects of PRR and its soluble form in local tissue RAS. Moreover, as an important part of vacuolar H + -ATPase, it also contributes to normal lysosome function and cell survival. Evidently, PRR participates in the pathogenesis of cardiovascular diseases and may be a potential therapeutic target of cardiovascular diseases. This review focuses on the effects of PRR and its soluble form on the physiological state, hypertension, myocardial ischemia reperfusion injury, heart failure, metabolic cardiomyopathy, and atherosclerosis. We aimed to investigate the possibilities and challenges of PRR and its soluble form as a new therapeutic target in cardiovascular diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
- Department of Cardiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
- Department of Cardiology, Shandong University of Traditional Chinese Medicine, Jinan, China.
- Key Laboratory of Cardiovascular Remodeling and Function Research, Qilu Hospital, Shandong University, Jinan, China.
- Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital and Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
Zitieren
APA
Wang, B., Jie, H., Wang, S., Dong, B., & Zou, Y. (2023). The role of (pro)renin receptor and its soluble form in cardiovascular diseases. Frontiers in Cardiovascular Medicine, 10. https://doi.org/10.3389/fcvm.2023.1086603
Vancouver
Wang B, Jie H, Wang S, Dong B, Zou Y. The role of (pro)renin receptor and its soluble form in cardiovascular diseases. Frontiers in Cardiovascular Medicine. 2023;10. doi:10.3389/fcvm.2023.1086603
BibTeX
@article{Wang2023,
author = {Wang, Boyang and Jie, Haipeng and Wang, Shuangxi and Dong, Bo and Zou, Yunzeng},
title = {The role of (pro)renin receptor and its soluble form in cardiovascular diseases},
journal = {Frontiers in Cardiovascular Medicine},
year = {2023},
volume = {10},
doi = {10.3389/fcvm.2023.1086603}
}
EUVIMED